We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$35.4B
AUM Growth
+$2.35B
Cap. Flow
+$2.2B
Cap. Flow %
6.21%
Top 10 Hldgs %
25.61%
Holding
774
New
196
Increased
195
Reduced
148
Closed
199

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$439M
2
DASH icon
DoorDash
DASH
+$385M
3
MSFT icon
Microsoft
MSFT
+$346M
4
BA icon
Boeing
BA
+$329M
5
AVGO icon
Broadcom
AVGO
+$324M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$928M
2
CRM icon
Salesforce
CRM
+$590M
3
NVDA icon
NVIDIA
NVDA
+$444M
4
TSLA icon
Tesla
TSLA
+$358M
5
BAC icon
Bank of America
BAC
+$353M

Sector Composition

Rank Sector Weight
1 Technology 19.01%
2 Consumer Discretionary 16.33%
3 Healthcare 11.24%
4 Industrials 11.17%
5 Real Estate 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBIO icon
476
Orchestra BioMed
OBIO
$272M
$4.15M 0.01%
1,000,000
-365,482
-27% -$1.47M
TERN
477
DELISTED
Terns Pharmaceuticals
TERN
$4.04M 0.01%
+100,000
New +$2.31M
BOW
478
Bowhead Specialty Holdings
BOW
$1.1B
$4.03M 0.01%
141,282
PSQH icon
479
PSQ Holdings
PSQH
$13.7M
$3.98M 0.01%
257,473
+99,555
+63% +$2.47M
IRON icon
480
Disc Medicine
IRON
$3.08B
$3.97M 0.01%
+50,000
New +$4.22M
BHST
481
BioHarvest Sciences
BHST
$48.7M
$3.93M 0.01%
+757,064
New +$6.05M
NKTX icon
482
Nkarta
NKTX
$167M
$3.86M 0.01%
2,084,840
+144
+0% +$288
ALGS icon
483
Aligos Therapeutics
ALGS
$47.7M
$3.84M 0.01%
412,000
QURE icon
484
uniQure
QURE
$3.14B
$3.61M 0.01%
151,058
+111,058
+278% +$4.29M
LRMR icon
485
Larimar Therapeutics
LRMR
$437M
$3.53M 0.01%
927,821
-959,348
-51% -$3.73M
ASST icon
486
Strive Inc
ASST
$1.05B
$3.53M 0.01%
239,468
-1,448,032
-86% -$34.6M
PHVS icon
487
Pharvaris
PHVS
$2.43B
$3.47M 0.01%
125,000
KLRS
488
Kalaris Therapeutics
KLRS
$95.9M
$3.4M 0.01%
+403,551
New +$2.58M
RCUS icon
489
Arcus Biosciences
RCUS
$3.63B
$3.4M 0.01%
+142,518
New +$2.91M
JCAP
490
Jefferson Capital
JCAP
$1.3B
$3.35M 0.01%
150,000
-100,000
-40% -$2.02M
STRW icon
491
Strawberry Fields REIT
STRW
$200M
$3.34M 0.01%
255,191
SI
492
Shoulder Innovations Inc
SI
$437M
$3.33M 0.01%
232,984
-218,552
-48% -$2.98M
DTIL icon
493
Precision BioSciences
DTIL
$207M
$3.32M 0.01%
+798,000
New +$4.53M
CBIO
494
Crescent Biopharma
CBIO
$639M
$3.11M 0.01%
+264,000
New +$3.36M
ORKA
495
Oruka Therapeutics
ORKA
$6.25B
$3.03M 0.01%
+100,000
New +$2.79M
KTOS icon
496
Kratos Defense & Security Solutions
KTOS
$11.8B
$2.98M 0.01%
+39,284
New +$3.22M
SVCO
497
Silvaco Group
SVCO
$247M
$2.97M 0.01%
732,824
+533,630
+268% +$2.65M
INN
498
Summit Hotel Properties
INN
$665M
$2.92M 0.01%
598,819
VIA
499
Via Transportation Inc
VIA
$1.95B
$2.9M 0.01%
100,000
+40,000
+67% +$1.65M
TNYA icon
500
Tenaya Therapeutics
TNYA
$170M
$2.85M 0.01%
+4,000,000
New +$5.44M

Similar funds

Alyeska Investment Group's Q4 2025 Portfolio in Review

As of Q4 2025, Alyeska Investment Group held 774 positions worth $35.4B, up 7.1% from $33.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Alyeska Investment Group deployed $2.2B of net new capital in Q4 2025, opening 196 new positions and adding to 195 existing holdings. Its largest new stake was DoorDash: 1,643,096 shares worth $372M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Twilio, an estimated $289M trimmed.

  • Alyeska Investment Group's largest Q4 2025 buy was DoorDash: 1,643,096 shares worth $372M.
  • Alyeska Investment Group added most to Amazon in Q4 2025, an estimated $439M increase.
  • Alyeska Investment Group's biggest Q4 2025 reduction was Twilio, cutting an estimated $289M.
  • Alyeska Investment Group fully exited Apple in Q4 2025, selling an estimated $928M.
  • Alyeska Investment Group's ten largest holdings make up 26% of its $35.4B portfolio in Q4 2025.
  • Alyeska Investment Group opened 196 new positions and closed 199 in Q4 2025.
  • Alyeska Investment Group's portfolio value rose 7.1% quarter-over-quarter to $35.4B.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.